8-K//Current report
IBERE PHARMACEUTICALS 8-K
Accession 0001104659-23-022265
CIK 0001835205operating
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 10:42 AM ET
Size
275.2 KB
Accession
0001104659-23-022265
Documents
- 8-Ktm236640d1_8k.htmPrimary
FORM 8-K
- EX-99.1tm236640d1_ex99-1.htm
EXHIBIT 99.1
- EX-101.SCHiber-20230215.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.DEFiber-20230215_def.xml
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
- EX-101.LABiber-20230215_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREiber-20230215_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLtm236640d1_8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-23-022265-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
IBERE PHARMACEUTICALS
CIK 0001835205
Entity typeoperating
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001835205
Filing Metadata
- Form type
- 8-K
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 10:42 AM ET
- Size
- 275.2 KB